Literature DB >> 28985512

The Anti-CRISPR Story: A Battle for Survival.

Karen L Maxwell1.   

Abstract

The last decade has seen the fields of molecular biology and genetics transformed by the development of CRISPR-based gene editing technologies. These technologies were derived from bacterial defense systems that protect against viral invasion. Elegant studies focused on the evolutionary battle between CRISPR-encoding bacteria and the viruses that infect and kill them revealed the next step in this arms race, the anti-CRISPR proteins. Investigation of these proteins has provided important new insight into how CRISPR-Cas systems work and how bacterial genomes evolve. They have also led to the development of important biotechnological tools that can be used for genetic engineering, including off switches for CRISPR-Cas9 genome editing in human cells.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas; CRISPR-Cas9; Cas9; Cascade; anti-CRISPR; bacteriophage; phage

Mesh:

Substances:

Year:  2017        PMID: 28985512     DOI: 10.1016/j.molcel.2017.09.002

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  26 in total

Review 1.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

2.  CRISPR-Cas9 Genome Editing in Human Cell Lines with Donor Vector Made by Gibson Assembly.

Authors:  Nirakar Sahoo; Victoria Cuello; Shreya Udawant; Carl Litif; Julie A Mustard; Megan Keniry
Journal:  Methods Mol Biol       Date:  2020

3.  Diverse Mechanisms of CRISPR-Cas9 Inhibition by Type IIC Anti-CRISPR Proteins.

Authors:  Yalan Zhu; Ang Gao; Qi Zhan; Yong Wang; Han Feng; Songqing Liu; Guangxia Gao; Alexander Serganov; Pu Gao
Journal:  Mol Cell       Date:  2019-03-05       Impact factor: 17.970

4.  PaCRISPR: a server for predicting and visualizing anti-CRISPR proteins.

Authors:  Jiawei Wang; Wei Dai; Jiahui Li; Ruopeng Xie; Rhys A Dunstan; Christopher Stubenrauch; Yanju Zhang; Trevor Lithgow
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

5.  Discovery of potent and versatile CRISPR-Cas9 inhibitors engineered for chemically controllable genome editing.

Authors:  Guoxu Song; Fei Zhang; Chunhong Tian; Xing Gao; Xiaoxiao Zhu; Dongdong Fan; Yong Tian
Journal:  Nucleic Acids Res       Date:  2022-03-21       Impact factor: 16.971

Review 6.  Precision Control of CRISPR-Cas9 Using Small Molecules and Light.

Authors:  Soumyashree A Gangopadhyay; Kurt J Cox; Debasish Manna; Donghyun Lim; Basudeb Maji; Qingxuan Zhou; Amit Choudhary
Journal:  Biochemistry       Date:  2019-01-22       Impact factor: 3.162

7.  Machine learning predicts new anti-CRISPR proteins.

Authors:  Simon Eitzinger; Amina Asif; Kyle E Watters; Anthony T Iavarone; Gavin J Knott; Jennifer A Doudna; Fayyaz Ul Amir Afsar Minhas
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

8.  CRISPR RNA and anti-CRISPR protein binding to the Xanthomonas albilineans Csy1-Csy2 heterodimer in the type I-F CRISPR-Cas system.

Authors:  Suji Hong; Donghyun Ka; Seo Jeong Yoon; Nayoung Suh; Migyeong Jeong; Jeong-Yong Suh; Euiyoung Bae
Journal:  J Biol Chem       Date:  2018-01-18       Impact factor: 5.157

9.  CRISPR-Cas in mobile genetic elements: counter-defence and beyond.

Authors:  Guilhem Faure; Sergey A Shmakov; Winston X Yan; David R Cheng; David A Scott; Joseph E Peters; Kira S Makarova; Eugene V Koonin
Journal:  Nat Rev Microbiol       Date:  2019-08       Impact factor: 60.633

10.  Structural basis of Staphylococcus aureus Cas9 inhibition by AcrIIA14.

Authors:  Hongnan Liu; Yuwei Zhu; Zebin Lu; Zhiwei Huang
Journal:  Nucleic Acids Res       Date:  2021-06-21       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.